MedTrace Logo

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

NCT04071080 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-06

No results posted yet for this study

Summary

During this study, participants will ingest 100 mg of fluorescein disodium or a placebo (no drug) mixed in GatoradeTM. Participants will then provide a urine sample after 10, 15, 20 or 30 minutes to see if the investigator can detect fluorescein fluorescence (light) in the urine.

Conditions

  • Urine Sample Authenticity

Interventions

DRUG

fluorescein sodium

Fluorescein sodium in 500mL Gatorade

DRUG

Placebo

500mL Gatorade

Sponsors & Collaborators

  • Medicor Research Inc.

    collaborator UNKNOWN

  • UpTru Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-22
Primary Completion
2019-11-28
Completion
2019-11-28
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071080 on ClinicalTrials.gov